Macular pigment, visual function, and macular disease among subjects with Alzheimer's disease: an exploratory study.

@article{Nolan2014MacularPV,
  title={Macular pigment, visual function, and macular disease among subjects with Alzheimer's disease: an exploratory study.},
  author={John M Nolan and Ekaterina Loskutova and Alan N. Howard and R Moran and Riona Mulcahy and Jim Stack and Maggie Bolger and Jessica L Dennison and Kwadwo Owusu Akuffo and Niamh Owens and D I Thurnham and Stephen Beatty},
  journal={Journal of Alzheimer's disease : JAD},
  year={2014},
  volume={42 4},
  pages={1191-202}
}
BACKGROUND The macula (central retina) contains a yellow pigment, comprising the dietary carotenoids lutein (L), zeaxanthin (Z), and meso-zeaxanthin, known as macular pigment (MP). The concentrations of MP's constituent carotenoids in retina and brain tissue correlate, and there is a biologically-plausible rationale, supported by emerging evidence, that MP's constituent carotenoids are also important for cognitive function. OBJECTIVE To investigate if patients with Alzheimer's disease (AD… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 6 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 57 references

The AREDS2 Study Group (2013) Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial

  • E Chew
  • 2015
1 Excerpt

Similar Papers

Loading similar papers…